Frontlight ResearchEarly access
Trial site
Institute of Science Tokyo Hospital
- 14running trials
- 1closed trial
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Dermatomyositis and polymyositis (myositis)4 trials
- Antiphospholipid syndrome2 trials
- Bladder cancer2 trials
- Immune thrombocytopenia (ITP)2 trials
- Ulcerative colitis2 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Crohn's disease1 trial
- Lupus (SLE)1 trial
- Multiple myeloma1 trial
- Multiple system atrophy1 trial
- Prostate cancer1 trial
- Stroke1 trial
- and 1 more
- Phase
- Phase 38 trials
- Phase 13 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Pfizer3 trials
- Chugai Pharmaceutical2 trials
- argenx1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Bayer1 trial
- and 7 more
Running trials
Recruiting
Not yet recruiting
Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Recruiting
Recruiting
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Recruiting
Enrolling by invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Recruiting
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Dermatomyositis and polymyositis (myositis)4 recruiting
- Antiphospholipid syndrome2 recruiting
- Bladder cancer2 recruiting
- Immune thrombocytopenia (ITP)2 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Multiple myeloma1 recruiting
- Multiple system atrophy1 recruiting
- Stroke1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026